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Cardiovascular disease risk is associated with excess body weight and elevated plasma free fatty acid (FFA)
concentrations. This study examines how an alternate-day fasting (ADF) diet high (HF) or low (LF) in fat
affects plasma FFA profiles in the context of weight loss, and changes in body composition and lipid profiles.
After a 2-week weight maintenance period, 29 women (BMI 30–39.9 kg/m2) 25–65 years old were
randomized to an 8-weekADF-HF (45% fat) diet or anADF-LF (25% fat) diet with 25% energy intake on fast
days and ad libitum intake on feed days. Body weight, BMI and waist circumference were assessed weekly
and body composition wasmeasured using dual x-ray absorptiometry (DXA). Total and individual FFA and
plasma lipid concentrations were measured before and after weight loss. Body weight, BMI, fat mass, total
cholesterol, LDL-C and triglyceride concentrations decreased (P , 0.05) in both groups. Total FFA
concentrations also decreased (P, 0.001). In theADF-LF group, decreases were found in severalmore FFAs
than in the ADF-HF group. In the ADF-HF group, FFA concentrations were positively correlated with waist
circumference. Depending on the macronutrient composition of a diet, weight loss with an ADF diet
decreases FFA concentrations through potentially different mechanisms.
R
isk of cardiovascular disease (CVD) has been associated with elevated plasma free fatty acid (FFA) con-
centrations1,2. Higher FFA concentrations in plasma have been associated with atherosclerosis, thrombosis
and hypertension1,3,4. Moreover, fatty acid composition has been shown to affect disease risk. For example,
high proportions of palmitic acid (1650) have been associated with higher triglycerides, low density lipoprotein
cholesterol (LDL-C), and total cholesterol5,6. Both expansion of adipose tissue and reduced FFA clearance
contribute to elevated FFA concentrations commonly seen in obesity7.
Weight loss through caloric restriction has been found to reduce many of the risk factors of CVD8–10. However,
the effects of weight loss on plasma FFA concentrations are unclear. Some studies have found no differences11,12,
while others have observed decreases13,14 in FFA concentrations as a result of weight loss. The varied results of
weight loss on FFA concentrations may depend on the dietary protocol and macronutrient distribution.
Alternate day fasting (ADF) has been shown to be effective for weight loss. ADF regimens include alternating
days of food consumption (feed days) with fast days where food intake is restricted to 25% of a person’s energy
needs in a day. Weight loss via ADF in adults has resulted in several cardioprotective changes in the blood lipid
profile including lower LDL cholesterol, and increased average LDL particle size15–17. Whether these ADF-
associated changes in weight loss extend to changes in plasma total FFA and FFA composition is unknown.
Additionally, we do not know how the macronutrient composition of ADF diets impact the FFA profile. The
objective of this study is to examine how ADF diets of different macronutrient compositions affect plasma FFA
profiles in the context of weight loss, and changes in body composition and lipid profiles.
Results
Subjects. Of the 35 women who started the study, 29 completed the trial. One subject was excluded due to
scheduling conflicts and five subjects were excluded due to not having lost any weight during the weight loss
period or noncompliance to the diet regime (n 5 2 in the ADF-HF group and n 5 3 in the ADF-LF group).
Baseline characteristics of the ADF-HF and ADF-LF groups are reported in Table 1. The groups were well
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Weight loss, body composition and plasma lipid concentrations.
During the initial weight maintenance period (week 1–2), no between-
group differences were found in any of the baseline characteristics.
Over the 8-week ADF diet period, both the ADF-HF and the ADF-LF
groups decreased (P , 0.05) in weight, BMI, fat mass, and waist
circumference WC (Table 1). There were no differences in the
extent of weight loss, changes in BMI, and WC between groups.
There was a trend (P 5 0.09) for a group*time interaction in fat
mass. Total cholesterol, LDL-C, and triglycerides decreased in both
groups (P, 0.05) during the weight loss period, whereas HDL-C did
not change over time. There was a trend (P 5 0.08) for a group*time
interaction in LDL-C whereby a larger decrease in LDL-C was
observed in the ADF-LF vs. the ADF-HF group.
FFA concentrations. With weight loss, total FFAs decreased (P ,
0.001) in the ADF-LF group by an average of 98.626 3.66 mmol/L. A
trend was found (P 5 0.05) in the ADF-HF group, where total FFA
decreased by 53.93 6 3.73 mmol/L (Figure 1). Changes in total FFA
concentrations did not differ between groups. Significant decreases
were observed in LNA (P 5 0.01), MA (P 5 0.049), AA (P 5 0.007),
LA (P 5 0.004), PA (P 5 0.001) and OA (P 5 0.001) in the ADF-LF
group (Table 2). In contrast, in the ADF-HF group there were
significant reductions in FFA concentrations of LNA (P 5 0.02)
and LA (P 5 0.048).
Relationship between changes in body composition and FFA
concentrations. Overall, a decrease in weight correlated with a
decrease in MA (r 5 0.391; P 5 0.039). In the ADF-LF group
weight loss correlated with decreases in DHA (r 5 0.642; P 5
0.013). In the ADF-HF group, lower fat mass correlated with
decreases in LA (r 5 0.635; P 5 0.015). Changes in waist
circumference in the ADF-HF group correlated with changes in
LNA (r 5 0.554; P 5 0.040), LA (r 5 0.700; P 5 0.005), PA (r 5
0.623; P 5 0.017), OA (r 5 0.610; P 5 0.027), and total FFA (r 5
0.623; P5 0.017) (Figure 2). No correlation was found between waist
circumference and any FFA in the ADF-LF group.
Relationship between changes in FFA and lipid concentrations. In
the ADF-HF group, changes in LNA concentrations negatively
correlated with total cholesterol (r 5 20.601; P 5 0.023) and HDL
(r 5 20.548; P 5 0.042). In the ADF-HF group, DHA negatively
correlated (r 5 20.573; P 5 0.032) with LDL-C. In the ADF-LF
group, LA was positively correlated (r 5 0.508; P 5 0.044) with
HDL-C.
Table 1 | Participant characteristics before (week 3) and after (week 10) the weight loss period
Group ADF-LF (n 5 15) ADF-HF (n 5 14)
Time Week 3 Week 10 Week 3 Week 10
Age (y) 43.2 6 2.3 42.4 6 3.0
Body weight (kg) 88.0 6 3.0 83.7 6 2.7a 89.2 6 2.8 84.5 6 2.7a
Body mass index (kg/m2) 34.4 6 0.8 32.7 6 0.7a 34.6 6 0.7 32.8 6 0.7a
% Fat 41.6 6 1.1 41.8 6 1.1 40.4 6 0.8 39.2 6 1.0
Fat mass (kg) 36.9 6 1.9 35.4 6 1.9a 36.1 6 1.4 33.2 6 1.5a
Waist circumference 98.4 6 1.9 90.4 6 2.3a 98.0 6 1.9 90.8 6 1.9a
Total cholesterol (mmol/L) 5.0 6 0.2 4.2 6 0.2a 5.0 6 0.3 4.3 6 0.2a
LDL cholesterol (mmol/L) 3.0 6 0.2 2.3 6 0.2a 2.8 6 0.2 2.3 6 0.2a
HDL cholesterol (mmol/L) 1.5 6 0.1 1.5 6 0.1 1.6 6 0.1 1.6 6 0.1
Triglycerides (mmol/L) 1.1 6 0.1 0.9 6 0.1a 1.4 6 0.2 1.3 6 0.2a
Glucose (mg/dL) 107.4 6 2.9 105.1 6 2.0 108.4 6 3.0 105.7 6 2.2
Values reported as mean 6 SEM. Alternate day fasting high fat diet (ADF-HF); alternate day fasting low fat diet (ADF-LF).
aP , 0.05 within group difference (from week 3 to week 10).
Figure 1 | Total FFAs in ADF groups fromweek 3 to week 10.Mean total fatty acid concentrations in ADF-HF and ADF-LF groups for weeks 3 and 10 of
the study. Values reported as mean 6 SEM. Alternate day fasting high fat diet (ADF-HF); alternate day fasting low fat diet (ADF-LF).
www.nature.com/scientificreports
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Discussion
Elevated total and individual plasma FFA concentrations observed in
obesity have been linked with cardiovascular disease risk1,2,5. During
weight loss, diet composition may affect FFA concentrations6,7. Our
study examined the effect of weight loss with a high fat ADF diet on
total and individual FFA concentrations compared to a low fat ADF
diet. We found that after weight loss, both groups had decreases in
total FFA concentrations. However, even though weight loss and
regional body composition results were similar between the two
groups, almost all FFAs in the ADF-LF group decreased whereas
changes were only noted in LA and LNA in the ADF-HF group.
Despite similar changes in waist circumference, decreases in WC
were correlated with decreases in several individual FFAs in the
ADF-HF group only.
In our study, we evaluated circulating concentrations of FFA.
Elevated total and individual plasma FFA concentrations observed
in obesity have been linked with cardiovascular disease risk and
atherosclerosis1,5,18,19. FFAs has been observed to impair vasodilation
in blood vessels through activating apoptosis in the endothelium20.
Furthermore, FFA is the main energy source for the myocardium;
high levels of FFA play a role in damaging the myocardium, exacer-
bating heart failure and leading to myocardial infarction21. Thus far,
no ADF studies have analysed circulating FFA profiles in order to
determine whether any cardio-protective changes occur at the FFA
level. The results of our FFA analysis show that weight loss with an
ADFdiet decreases total FFA concentrations, and that both theADF-
LF and ADF-HF diets could be effective at reducing FFA concentra-
tions. Though no significant group*time interactions were observed,
the decrease in total FFA concentrations with an ADF-LF diet was
almost 2 times that of the ADF-HF diet. Previously, effects of weight
loss on FFA concentrations appear to be variable with some studies
showing decreases in FFA11,13,14, while others show no change22–24 or
even increases25–27 in FFA. Some of these studies achieved weight loss
using a very low calorie diet, surgery or hypocaloric diets with vary-
ing macronutrient composition. Therefore, the dietary regimen used
in these studies during the weight loss period may be a source of
variability in changes of FFA to weight loss.
Individual FFA concentrations have been shown to contribute to
CVD risk differently. Thrombosis and arrhythmia have been assoc-
iated with a number of saturated FFA including palmitic acid28,29.
Palmitic, oleic, andmyristic acid have been positively associated with
lipid risk factors of CVD6. Our study also showed that LA, DHA and
LNA were associated with lipid risk factors of CVD. Patients post-
myocardial infarction were also shown to have greater palmitic and
oleic acid and lower linoleic acid compared to age-matched con-
trols30. With an ADF-LF diet, we observed a significant reduction
in more types of FFAs (LNA, MA, AA, LA, PA and OA) vs. in the
ADF-HF group (LNA and LA). This suggests that the low fat ADF
diet was more effective at decreasing FFA concentrations vs. the high
fat ADF diet. To our knowledge this is the first study to examine
changes in individual FFA composition in the context of a weight loss
program using ADF with varying macronutrient composition.
Normal weight participants who consumed a high fat diet also
observed changes in the proportion of LA and LNA compared with
a low fat diet31. These results suggest that LA and LNA are more
sensitive to changes with the consumption of a high fat diet.
Therefore, combining a high fat diet with weight loss via an ADF
protocol would likely have a greater effect on these FFAs, as observed
in this study.
There were strong correlations in the ADF-HF group where
decreases in waist circumference were associated with decreases in
several FFAs. In contrast, there were no such correlations between
waist circumference and FFAs in the ADF-LF group. Waist circum-
ference is considered a surrogate marker of abdominal adiposity and
visceral fat mass32. We hypothesize that in weight loss, the levels of
dietary fat intake and changes in abdominal fat have a collective effect
on decreases in FFA concentrations. The relatively larger contri-
bution of a diet low in fat to changes in FFA concentrations may
mask the relationship between abdominal fat mass and FFA concen-
trations. In contrast, weight loss with a high fat diet may have a
smaller effect in lowering FFA concentrations in comparison to the
greater effect of decreases in abdominal fat. Regardless of the relative
contribution of dietary fat content on FFA lowering, changes in
abdominal fat mass during weight loss with an ADF diet resulted
in cardioprotective changes in FFA concentrations.
Amajor strength of the study was that both the ADF-LF andADF-
HF group were matched for body composition. Additionally, body
composition changed equally in the ADF-LF and ADF-HF groups.
Thus, the effects of a HF and LF diet on FFA concentrations could be
examined without the confounding effects of changes in body com-
position. Additionally, since all themeals were provided and the ratio
of SFA:MUFA:PUFA was similar in the high and low fat diets, the
effects of overall fat content on FFA concentrations could be isolated.
Due to a communication error during sample processing, hor-
monal regulators of lipolysis were not measured. While insulin inhi-
bits FFA release, other hormones such as epinephrine stimulate FFA
release over a wide range33,34. Thus, we are not able to determine the
mechanisms that underlie the changes we saw in FFA composition as
a result of a ADF-HF or ADF-LF diet. Another limitation of this
study was that both intervention groups lost weight during the
weight maintenance period. However, there were no between group
differences in weight changes. It is conceivable that decreases in
weight during the weight maintenance period diluted observable
decreases in FFA concentrations during theweight loss that followed.
Table 2 | FFA changes during an ADF-LF and ADF-HF weight loss diet
ADF-LF ADF-HF
FFA (mmol/L) Week 3 Week 10 Week 3 Week 10
LNA 11.08 6 0.31 10.96 6 0.22a 12.07 6 0.38 11.59 6 0.29a
DHA 11.61 6 0.21 11.36 6 0.31 12.01 6 0.25 11.59 6 0.30
MA 19.79 6 0.51 19.15 6 0.46a 20.72 6 0.46 20.14 6 0.48
AA 11.88 6 0.38 11.34 6 0.34a 12.67 6 0.42 12.50 6 0.28
LA 79.92 6 2.98 75.02 6 3.47a 89.39 6 5.42 85.10 6 3.38a
PA 48.35 6 5.21 39.99 6 5.85b 60.75 6 6.41 60.00 6 5.56
OA 37.71 6 3.95 31.47 6 4.26b 46.10 6 4.10 45.14 6 3.60
Total FFA 260.89 6 22.69 162.27 6 24.35b 264.14 6 27.89 210.21 6 24.16
a-linolenic acid (LNA), docosahexanoic acid (DHA), myristic acid (MA), arachadonic acid (AA), linoleic acid (LA), palmitic acid (PA) and oleic acid (OA).
Values reported as mean 6 SEM. Alternate day fasting high fat diet (ADF-HF); alternate day fasting low fat diet (ADF-LF).
aP , 0.05 within group difference (from week 3 to week 10).
bP , 0.001 within group difference.
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Aswe observed significant changes in FFA concentrations during the
weight loss period, the effect of the initial weight lost during the
weight maintenance period on FFA concentrations was likely to be
minimal.
In summary, our findings are the first to demonstrate that a weight
loss intervention with ADF-HF or ADF-LF can reduce total and
individual plasma FFA concentrations though it appears that a LF
diet may be more effective at lowering FFA. Though both diets
equally reduced waist circumference, we found several strong corre-
lations betweenWC and changes in individual FFAs in the ADF-HF
group that were not present in the ADF-LF group. Since there were
no differences in changes in FFA composition between groups, the
correlations between WC and FFAs found only in the ADF-HF
group imply that ADF-HF and ADF-LF diets may lower FFA con-
centrations through different mechanisms. Overall, the decreases in
FFA concentrations after ADF weight loss may be cardio-protective.
Future studies might include individual FFA profiles when evalu-
ating macronutrient composition, as the effects of specific FFAs in
this context are not well known.
Methods
Subjects. Participants were recruited from the Chicago area and were randomized by
stratified random sampling based on BMI and age. Subjects were then randomized to
a ADF-HF or ADF-LF group, as previously described35. Briefly, potential participants
were eligible if they were female, 25 to 65 years of age, with a body mass index (BMI)
between 30 and 39.9 kg/m2. Participants had to be weight stable for 3 months prior to
the beginning of the study, sedentary or lightly active, non-smokers, non-diabetic,
and not taking any medications. Postmenopausal women were included provided
they maintained a stable dose of their current hormone replacement therapy. All
volunteers provided written informed consent. All study protocols were carried our in
accordance with guidelines approved by the Office for the Protection of Research
Subjects at the University of Illinois at Chicago, Chicago, USA and the Human
Research Ethics Committee at Concordia University, Montreal, Canada.
Diet. Food provided was prepared in the metabolic kitchen of the Human Nutrition
Research Unit at the University of Illinois, Chicago. All subjects underwent a 2-week
high fat or low fat weightmaintenance period (week 1–2), followed by an 8-weekADF
weight-loss diet (week 3–10). TheADF-HF group received 45% fat (14% saturated fat,
20% monounsaturated fat, 11% polyunsaturated fat) and the ADF-LF group
received 25% fat (6% saturated fat, 13% monounsaturated, 6% polyunsaturated
fat). A detailed description of the diet composition and energy requirements is
provided elsewhere35. Subjects were provided with 3 meals on each feed day and
one meal on each fast day. All subjects were asked to consume their meals at the
same time each day.
Weight loss and body composition. Body weight measurements were taken weekly
following an overnight fast (to the nearest 0.5 kg) in light clothing and without shoes
using a balance beam scale (HealthOMeter; Sunbeam Products, Boca Raton, FL).
Height was measured using a wall-mounted stadiometer (to the nearest 0.1 cm). BMI
was assessed as kg/m2. Total fat mass and fat-free mass was determined by dual energy
X-ray absorptiometry (DXA) (QDR 4500 W, Hologic Inc. Arlington, MA) at baseline,
week 3 and week 10. Waist circumference was taken by a flexible measuring tape (to the
nearest 0.1 cm), midway between the lower costal margin and super iliac crest during a
period of expiration. Participants wore a pedometer (Digi-Walker SW-200, Yamax
Corp., Japan) during the study to ensure maintenance of regular physical activity habits.
Figure 2 | Relationship between decreases in waist circumference (WC) and changes in a-linolenic acid (LNA; Panel a), linoleic acid (LA; Panel b),
palmitic acid (PA; Panel c), and oleic acid (OA; Panel b). Each panel shows a significant relationship (P, 0.05) between changes inWC and the FFAwith
an ADF-HF diet. There were no relationships between changes in WC and FFAs with an ADF-LF diet.
www.nature.com/scientificreports
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Plasma lipid and free fatty acid analysis. Blood samples were collected in the
morning after an overnight fast at baseline, week 3 andweek 10. Exercise, alcohol, and
coffee were restricted for 24 h before each visit. Blood was centrifuged for 10 min at
520 G in 4uC and plasma was stored at 280uC until analyzed. Plasma lipid samples
were analysed as previously described35. FFA were quantified via ultra performance
liquid chromatography (UPLC) (Waters ACUITY UPLC, Milford, Massachusetts).
a-linolenate (LNA), docosahexanoate (DHA), arachadonate (AA), and linoleate (LA)
standards were purchased from Sigma-Aldrich. Myristate (MA), palmitate (PA) and
oleate (OA) standards were purchased from Nu-Check prep. All standards were
.99% pure. FFA standards were dissolved in 4% fatty acid free albumin phosphate
buffer. The individual standard solutions were combined to form an external mixed
FFA standard. D31 palmitate (Cambridge Isotope Laboratories, Inc., Tewksbury,
Massachusetts) was used as an internal standard and added to plasma samples and
external standards. Plasma samples and the mixed FFA standards were extracted and
derivatized as previously described36. Samples were then transferred to a UPLC vial in
20580H2O:acetonitrile solution and 10 mL were injected onto a 55uC heated Acquity
UPLC BEH C18 1.7 mM 2.1 3 150 mm column eluted with H2O:acetonitrile 20580
at a mL/min rate. Peaks were detected with a photodiode array (PDA) detector at
242 nm.
Statistical methods. All data was analyzed using SPSS software (version 20.0, SPSS
Inc., Chicago, IL). Results are presented as mean 6 SEM. Normality was assessed by
Shapiro-Wilks tests. Independent samples t-tests were used to test baseline
differences between groups. Repeated-measures ANOVA were used to assess for
significant differences with time as the within-subject factor and diet as the between-
subject factor. Post-hoc analyses were done using a Tukey’s test. Pearson correlations
were performed to assess the relationships between body composition and FFA
concentrations. Differences were considered significant at P , 0.05.
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